Acute promyelocytic leukaemia (APL) represents a unique and once highly fatal subtype of acute myeloid leukaemia that is now considered among the most curable forms of haematological malignancies.
June 29, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for cefepime hydrochloride 500 mg, 1 g, and 2 g base/vial for parenteral administration in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback